Monoclonal antibody therapies continue to neutralize SARS-CoV-2 variants currently in circulation, including omicron BA.4/5, according to laboratory findings from the Francis Crick Institute and the National Institute ...
Oct 7, 2022
0
65
A team of scientists and doctors from the KK Women's and Children's Hospital (KKH), Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and the Institute for Health Innovation and Technology has ...
Oct 5, 2022
0
39
A study conducted by Ludwig Johns Hopkins researchers, their colleagues at Johns Hopkins University and Ludwig alumni at the Walter and Eliza Hall Institute of Medical Research (WEHI), in Melbourne, examined whether circulating ...
Sep 20, 2022
0
64
Immune checkpoint inhibitor (ICI) therapy is a type of treatment for melanoma, the deadliest form of skin cancer, which blocks proteins on tumor or immune cells that prevent the immune system from killing cancer cells.
Sep 19, 2022
0
1486
An international team of researchers, writing in the journal Nature Medicine, advises that strong care needs to be taken not to misuse or overuse machine learning (ML) in health care research.
Sep 13, 2022
0
42
New research has suggested that recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the monkeypox virus observed in the current outbreak (MPXV-2022).
Sep 9, 2022
0
45
Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and ...
Aug 22, 2022
0
177
An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy ...
Aug 9, 2022
0
945
Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years—in hopes of better fighting the tick-borne threat.
Aug 9, 2022
0
196
Researchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesized a small molecule that could be a more accessible and effective alternative to an antibody that is successfully used to ...
Aug 8, 2022
0
3679
